CARL — CARLSMED, INC.

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1794546 ·
Last close
$17.74
Market Cap
$486.15M
52W High
$19.15
52W Low
$8.50
ADV30
124,932
Next earnings
2026-11-10
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 21,554,000 16,665,000 -12,701,000 -12,245,000 115,270,000 35,945,000 39,596,000
Jun 2026 18,940,000 14,542,000 -11,036,000 -10,510,000 118,202,000 46,244,000 33,956,000
Mar 2026 16,116,000 12,425,000 -9,276,000 -8,696,000 118,769,000 73,016,000 26,521,000
Dec 2025 15,165,000 11,608,000 -9,318,000 -8,613,000 130,120,000 85,793,000 31,251,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-34,360,000
Investing CF
$-45,890,000
Financing CF
$822,000
CapEx
$-1,788,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.48
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-132,294,000
Inventory
$2,987,000
Receivables
$16,884,000
ST Investments
$44,262,000
EBIT TTM
$-38,794,000
Pretax Income TTM
$-40,064,000
Interest Exp TTM
$1,270,000
Analysts
5

Yahoo Snapshot (yfinance, live)

Total Revenue
$71,775,000
EBITDA
$-41,878,000
Free Cash Flow
$-22,692,624
Enterprise Value
$410,736,000
Total Cash
$80,207,000
Total Debt
$21,785,000
Shares Out
27,404,088
Trailing EPS
$-1.13
Book Value
$2.76
ROE
-43.9%
ROA
-21.2%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 3y)

Revenues vs Net Income (last 3y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 50,511,000 -30,574,000 -29,634,000 130,120,000 31,251,000 98,869,000 -28,977,000
Dec 2024 27,165,000 -24,122,000 -24,257,000 51,824,000 122,454,000 -70,630,000 -25,466,000
Dec 2023 13,778,000 -18,591,000 -18,898,000 14,024,000 60,154,000 -46,130,000 -17,480,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$118,202,000
Forward EPS
$-1.56

Peers — same industry

TickerNameMarket CapLastDaily %
ANGO ANGIODYNAMICS INC $483.21M $11.49 —
RCEL AVITA Medical, Inc. $495.50M $15.77 —
MDXG MIMEDX GROUP, INC. $464.04M $3.18 —
AVR Anteris Technologies Global Corp. $518.67M $5.32 —
OBIO Orchestra BioMed Holdings, Inc. $548.57M $6.97 —

News headlines (Yahoo Finance, 1h cache)

Carlsmed to Participate in Upcoming Investor Conferences
2026-11-16 21:01 · Yahoo
Carlsmed (CARL) Stock Sees Fair Value Lift After Analysts React To Q3 Strength
2026-11-16 07:07 · Yahoo
DeGen Medical Moves to Dismiss Carlsmed Patent Suit, Vows to Fight Remaining Claims
2026-11-15 22:50 · Yahoo
Carlsmed Inc (CARL) (Q3 2026) Earnings Call Highlights: Revenue Surges 65% as Guidance Raised ...
2026-11-11 05:08 · Yahoo
Carlsmed (CARL) Q3 2026 Earnings Call Transcript
2026-11-11 03:19 · Yahoo
Carlsmed Q3 Earnings Call Highlights
2026-11-11 00:14 · Yahoo
Carlsmed, Inc. (CARL) Reports Q3 Loss, Tops Revenue Estimates
2026-11-10 21:40 · Yahoo
Carlsmed® Reports Third Quarter 2026 Financial Results and Raises Full-Year Guidance
2026-11-10 21:01 · Yahoo
Carlsmed, Inc. to Report Third Quarter 2026 Financial Results on November 10, 2026
2026-10-27 20:30 · Yahoo
Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System
2026-10-14 13:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.